Learn More About Participating in a Study

  • This field is for validation purposes and should be left unchanged.

Schizophrenia is a chronic mental health disorder that affects how a person thinks, feels, and behaves. It’s characterized by episodes of psychosis, involving delusions, hallucinations, as well as disorganized thinking and behavior. Early diagnosis and treatment are important for improving the long-term outlook for people with schizophrenia, helping them to lead fulfilling, productive lives despite the challenges of the disorder.

APG Research is testing a new medication to treat symptoms of Schizophrenia in patients ages 13-17. Please contact us for more information about this opportunity.

Patients who qualify to participate in a study will receive:

  • Assessments by a Board Certified Psychiatrist
  • Investigational medication at no cost
  • Study-related care and monitoring
  • Compensation for time and travel

APG Research provides extensive service to our sponsors, physicians and research patients. Our team has a combined 40 years of clinical research experience in adult and pediatric studies including Major Depression, Autism, Anxiety, Bipolar, OCD, ADHD and Schizophrenic Disorders.

Our research team has two full-time Board Certified Psychiatrists or PIs on site, a full-time rater, a full-time ARNP, four full-time CRCs, two assistant CRCs, and three Laboratory Technicians that specialize in Depression Treatments, ADHD Treatments and much more.

We screen/select our study patients from our private practice (APG Health) database. APG Health Group is the largest outpatient practice in the greater Orlando Area with fourteen clinicians treating 150-200 patients a day.

APG Research treats patients with Autism/PDD-NOS/Asperger’s, Depression, Bipolar Disorder, Anxiety, Panic Disorders, ADD/ADHD, Schizophrenia, and other Mental Health Disorders. We see patients from ages 3 years to 70 years of age.